Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMS American Shared Hospital Services	$2.59 +0.4%	$2.49	$2.27 ▼ $4.60	$16.64M	0.31	4,546 shs	1,617 shs
ATPC Agape ATP	$1.21 -6.5%	$1.39	$0.90 ▼ $3.49	$64.71M	-0.97	46,116 shs	207,071 shs
BDSX Biodesix	$0.40 +3.5%	$0.33	$0.17 ▼ $2.04	$56.23M	0.99	1.55 million shs	853,885 shs
NAKA KindlyMD	$15.02 +13.4%	$12.15	$0.65 ▼ $34.77	$100.78M	34.35	554,710 shs	885,260 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMS American Shared Hospital Services	+0.39%	+4.44%	+6.58%	+0.78%	-3.36%
ATPC Agape ATP	-6.49%	-10.04%	-11.68%	-40.98%	-42.05%
BDSX Biodesix	+3.52%	-11.19%	+29.65%	+31.81%	-76.92%
NAKA KindlyMD	+13.36%	+100.27%	+27.61%	+1,501,999,900.00%	+1,501,999,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMS American Shared Hospital Services	1.2239 of 5 stars	0.0	3.0	0.0	0.0	3.3	1.7	0.6
ATPC Agape ATP	0.1353 of 5 stars	0.0	3.0	0.0	0.0	1.1	0.0	0.0
BDSX Biodesix	3.189 of 5 stars	3.4	5.0	0.0	0.0	1.5	2.5	0.6
NAKA KindlyMD	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMS American Shared Hospital Services	0.00	N/A	N/A	N/A
ATPC Agape ATP	0.00	N/A	N/A	N/A
BDSX Biodesix	2.80	Moderate Buy	$1.75	340.81% Upside
NAKA KindlyMD	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest AMS, ATPC, NAKA, and BDSX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/21/2025	BDSX Biodesix	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Outperform ➝ Sector Outperform	$3.00 ➝ $2.00

(Data available from 8/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMS American Shared Hospital Services	$28.34M	0.59	$0.89 per share	2.91	$4.68 per share	0.55
ATPC Agape ATP	$1.32M	45.84	N/A	N/A	$0.48 per share	2.52
BDSX Biodesix	$71.32M	0.82	N/A	N/A	$0.01 per share	39.70
NAKA KindlyMD	$2.72M	42.02	N/A	N/A	$1.18 per share	12.73

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMS American Shared Hospital Services	$2.19M	$0.60	N/A	8.63	N/A	-8.27%	-7.97%	-3.89%	N/A
ATPC Agape ATP	-$2.47M	-$0.41	N/A	∞	N/A	-183.13%	-27.66%	-24.53%	N/A
BDSX Biodesix	-$42.93M	-$0.29	N/A	N/A	N/A	-53.66%	-269.67%	-43.94%	N/A
NAKA KindlyMD	-$3.62M	-$0.86	N/A	∞	N/A	-244.00%	-131.09%	-106.04%	N/A

Latest AMS, ATPC, NAKA, and BDSX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2025	Q2 2025	ATPC Agape ATP	N/A	-$0.01	N/A	-$0.01	N/A	N/A
8/7/2025	Q2 2025	BDSX Biodesix	-$0.07	-$0.08	-$0.01	-$0.08	$18.47 million	$20.02 million
8/5/2025	Q2 2025	NAKA KindlyMD	N/A	-$0.34	N/A	-$0.35	N/A	$0.41 million
5/15/2025	Q1 2025	ATPC Agape ATP	N/A	-$0.07	N/A	-$0.07	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMS American Shared Hospital Services	N/A	N/A	N/A	N/A	N/A
ATPC Agape ATP	N/A	N/A	N/A	N/A	N/A
BDSX Biodesix	N/A	N/A	N/A	N/A	N/A
NAKA KindlyMD	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMS American Shared Hospital Services	0.58	1.87	1.87
ATPC Agape ATP	N/A	24.68	24.64
BDSX Biodesix	41.11	2.14	2.22
NAKA KindlyMD	N/A	13.00	13.00

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMS American Shared Hospital Services	23.16%
ATPC Agape ATP	0.01%
BDSX Biodesix	20.96%
NAKA KindlyMD	N/A

Insider Ownership

Company	Insider Ownership
AMS American Shared Hospital Services	23.80%
ATPC Agape ATP	9.67%
BDSX Biodesix	30.10%
NAKA KindlyMD	40.79%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMS American Shared Hospital Services	10	6.45 million	4.92 million	Not Optionable
ATPC Agape ATP	40	50.01 million	45.17 million	Not Optionable
BDSX Biodesix	220	146.63 million	102.50 million	Optionable
NAKA KindlyMD	N/A	7.61 million	4.50 million	N/A

AMS, ATPC, NAKA, and BDSX Headlines

Recent News About These Companies

KindlyMD Completes Merger with Nakamoto to Establish Bitcoin Treasury

August 14 at 4:19 PM | accessnewswire.comA

Nakamoto Holdings Appoints Amanda Fabiano as Chief Operating Officer

August 6, 2025 | accessnewswire.comA

KindlyMD (NASDAQ:NAKA) Announces Quarterly Earnings Results

August 6, 2025 | marketbeat.com

Kindly MD Reports Financial Results for Second Quarter 2025

August 5, 2025 | accessnewswire.comA

KindlyMD and Nakamoto Announce the Filing of the Definitive Information Statement in Connection with Proposed Merger

July 22, 2025 | businesswire.com

YZi Labs Announces Support for 10X Capital's BNB Treasury Company in the U.S.

July 9, 2025 | globenewswire.com

KindlyMD Raises Another $51.5M for Bitcoin Treasury Strategy

June 20, 2025 | coindesk.com

KindlyMD and Nakamoto Announce an Additional $51.5 Million In PIPE Financing To Support Bitcoin Treasury Efforts

June 20, 2025 | businesswire.com

Nakamoto Holdings Appoints Tyler Evans as Chief Investment Officer to Lead Bitcoin-Native Capital Deployment

June 18, 2025 | businesswire.com

Nakamoto Holdings to Participate in ICR Conference Spotlight Series

June 17, 2025 | businesswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

AMS, ATPC, NAKA, and BDSX Company Descriptions

American Shared Hospital Services NYSEAMERICAN:AMS

$2.59 +0.01 (+0.39%)

Closing price 08/14/2025 04:10 PM Eastern

Extended Trading

$2.58 0.00 (-0.19%)

As of 04:09 AM Eastern

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

Agape ATP NASDAQ:ATPC

$1.21 -0.08 (-6.49%)

Closing price 08/14/2025 03:59 PM Eastern

Extended Trading

$1.24 +0.03 (+2.07%)

As of 08/14/2025 07:53 PM Eastern

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Biodesix NASDAQ:BDSX

$0.40 +0.01 (+3.52%)

Closing price 08/14/2025 04:00 PM Eastern

Extended Trading

$0.39 0.00 (-1.01%)

As of 04:25 AM Eastern

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

KindlyMD NASDAQ:NAKA

$15.02 +1.77 (+13.36%)

As of 08/14/2025 04:00 PM Eastern

Kindly MD, Inc. (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. Through its focus on an embedded model of prescriber and therapist teams, KindlyMD develops patient-specific care programs with a specific mission to reduce opioid use in the patient population while successfully treating patients with effective and evidence-based non-opioid alternatives in close conjunction with behavioral therapy. Beyond its treatment of patients, KindlyMD collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The Company captures all relevant datapoints to assist and appropriately treat each individual patient. This also results in valuable data for the Company and the Company’s investors. We strive to become a source for evidence-based guidelines, data, treatment models, and education in the fight against the opioid crisis in America. Business Revenue Streams We currently earn revenue through (i) patient care services related to medical evaluation and treatment and (ii) product retail sales. Our forecasted plan is to operate across various revenue streams: (i) medical evaluation and treatment visits reimbursed by Medicare, Medicaid, and commercial insurance payers as well as self-pay services, (ii) data collection and research, (iii) education partnerships, (iv) service affiliate agreements, and (v) retail sales. Our principal executive offices are located at 5097 S 900 E, Suite 100 Salt Lake City, UT.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time